PTHLH and osteoporosis: The novel biochemical theory of modulating BRRS via tooth movement offers new clinical options for treating osteoporosis, including the use of sclerostin-inhibiting antibodies and intermittent periodontal PTHrP to promote bone apposition (Figure 8).